# Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-or-placebo-with-chemoradiotherapy-followed-by-pembrolizumab-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Domenica Lorusso,Yang Xiang,Kosei Hasegawa,Giovanni Scambia,Manuel Leiva,Pier Ramos-Elías,Alejandro Acevedo,Vladyslav Sukhin,Noelle Cloven,Andrea Juliana Gomes,Fernando Contreras Mejía,Ari Reiss,Ali̇ Ayhan,Jung‐Yun Lee,Valeriya Saevets,Flora Zagouri,Lucy Gilbert,Jalid Sehouli,Ekkasit Tharavichitkul,Kristina Lindemann,Roberta Lazzari,Chih‐Long Chang,Rudolf Lampé,Hong Zhu,Ana Oaknin,Melissa Christiaens,Stephan Polterauer,Tomoka Usami,Kan Li,Karin Yamada,Sarper Toker,Stephen J. O’Keefe,Sandro Pignata,Linda Duska |
| Citations | 374 |
| DOI | 10.1016/s0140-6736(24)00317-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4393965986 |
| PMID | 38521086 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Domenica Lorusso](https://scholariq.org/researchers/domenica-lorusso/)
- [Giovanni Scambia](https://scholariq.org/researchers/giovanni-scambia/)
- [Flora Zagouri](https://scholariq.org/researchers/flora-zagouri/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

## Paper topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
